{"name":"Patara Pharma","slug":"patara-pharma","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxPY1NBd0pfeWgwWGl5Y19oeDZzdXFxVkpxbFExTk04dklCMnlfOHRCRVdEOUs3cmk4c2szcVdUSVc1NHJqZXBEODNxMkZJYWdlbnVlUWl2aW1vWWRDN2RvWWkweTBqaTcxaml0TkQwZHNyWlhxYzc0cjBJYUxDeTY5ZFExVEdpU1A2cHdHYTd1cmMwdWpyZVpFdTJTdzRDZw?oc=5","date":"2026-04-06","type":"pipeline","source":"openPR.com","summary":"Mastocytosis Therapeutics Market Size in the 7MM is projected - openPR.com","headline":"Mastocytosis Therapeutics Market Size in the 7MM is projected","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxNTk9La3ZZV0VCZ0Z4REhuX2c4anFGQ3k1cUJERzVaS0QzSGhwZTVaSGg2OVJmVUVDZ0NpdFhOQmszRjdhaVJ2dHZlbEZhU1hucWQ1SHJzbVN6UzdhdzRsU1JNVjhQY29VYTFEZG9qTmNrZmQtS2U2UW5hRGFZNHoxVEFsU1M1YlB0QTZiQ1BpeEhDclk4UG5xeEtYZXk2Q0JZdU5lN2tZcEpMNTVuUmpFZkY0eGo?oc=5","date":"2025-08-13","type":"pipeline","source":"San Diego Business Journal","summary":"AeroRx ‘Full Speed Ahead’ on Developing Nebulized COPD Treatment - San Diego Business Journal","headline":"AeroRx ‘Full Speed Ahead’ on Developing Nebulized COPD Treatment","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxQSXh5T3ZqU1V3QWZSeXFZaUlwTXBTbVFZNzRXWU83UGV1UFRKSmNkdVJRdDFMcFpSZXIwdkhXY1k5b3lRek9ZbzlnU1BWbUVFWlZzaWZqR01PV3ZxWmFqX25vZTl0R1lIc2p5MDBoYmR4ejFsXzR2SENPSlozODVmWnNUQnk2Q1BWS0gzVGtZNC05YmVTNG1LaUVlZlhHQW51UkZmSkZ6UQ?oc=5","date":"2019-09-17","type":"trial","source":"Fierce Biotech","summary":"Biogen axes phase 2 study of lung-scarring med due to 'safety concerns' - Fierce Biotech","headline":"Biogen axes phase 2 study of lung-scarring med due to 'safety concerns'","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4wFBVV95cUxQMk9ycXJrQ2dERVh4bWVyUUZxeFhQSTYxdWozc21DQk12UjVQNnhVaGFvUmJVdlJ4dmFmMFB1bUJWZ0NuWmRFZk00M0J0bTliLVNRSzlMNnd3R2VxeGxJX0lGODBVSjFiNXhzcjZGRmpqRUtZckRqSUJFNlZtNXhRYWdoY3R3MTROb0xNb2hNNHZrc1Z2VlJzNHRCZ3BJRW5JMWszWG1jcThLc0lDdi12cnN1UUJCWmJNSUpFc2RUSTdXUHRpeFh0dGhBNFRuQ1FJRHlnRFRxRGR1LXVWM3BlaFpxTdIB4wFBVV95cUxQMk9ycXJrQ2dERVh4bWVyUUZxeFhQSTYxdWozc21DQk12UjVQNnhVaGFvUmJVdlJ4dmFmMFB1bUJWZ0NuWmRFZk00M0J0bTliLVNRSzlMNnd3R2VxeGxJX0lGODBVSjFiNXhzcjZGRmpqRUtZckRqSUJFNlZtNXhRYWdoY3R3MTROb0xNb2hNNHZrc1Z2VlJzNHRCZ3BJRW5JMWszWG1jcThLc0lDdi12cnN1UUJCWmJNSUpFc2RUSTdXUHRpeFh0dGhBNFRuQ1FJRHlnRFRxRGR1LXVWM3BlaFpxTQ?oc=5","date":"2018-09-28","type":"pipeline","source":"Newswise","summary":"Trustees of Sanford Burnham Prebys Medical Discovery Institute Elect New Board Leadership, Welcome New Board Member | Newswise - Newswise","headline":"Trustees of Sanford Burnham Prebys Medical Discovery Institute Elect New Board Leadership, Welcome New Board Member | Ne","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxNdmlfeEJvM2NucmhEc015SGVRUTI2MGNnZlVycjFZeWtKVkJjaHY3WG1QV2ZURmFmbVAxZmsyb3FLWExsaWVlZDVpWldqcXBUQWdURnpOYml5YUVHSjdOSHRYZXVSWS1JNzRicUp6WWJUMW4zdGRfNU5LcDNEQXd0bFdlaXg1VFY5M0llcDlfNVM2dFMyR0JMQmln?oc=5","date":"2018-09-18","type":"trial","source":"Fierce Biotech","summary":"Roivant launches lung-focused Respivant with phase 2 IPF drug - Fierce Biotech","headline":"Roivant launches lung-focused Respivant with phase 2 IPF drug","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}